Alimentary Pharmacology & Therapeutics

Review article: antibiotic-induced Clostridium difficile infection
pp. 835-841(7)
Authors: Settle, C.D.; Wilcox, M.H.

Review article: symptom improvement through eradication of Helicobacter pylori in patients with non-ulcer dyspepsia
pp. 843-850(8)
Authors: Laheij, R.J.F.; Jansen, J.B.M.J.; van de Lisdonk, E.H.; Severens, J.L.; Verbeek, A.L.M.

Review article: methotrexate in gastroenterology-dangerous villain or simply misunderstood?
pp. 851-858(8)
Authors: Tang, H.; Neuberger, J.

Review article: beta3-adrenoceptor agonists-future anti-inflammatory drugs for the gastrointestinal tract?
pp. 859-863(5)
Author: Anthony, A.

Clinical economics review: cost-effectiveness of treatment alternatives for gastro-oesophageal reflux disease
pp. 865-873(9)
Authors: Sridhar, S.; Huang, J.; O'brien, B.J.; Hunt, R.H.

The effects of cisapride on the topography of oesophageal peristalsis
pp. 875-882(8)
Authors: Staiano, A.; Clouse, R.E.

Sublingual nitroglycerine: effects on contractile activity of the distal oesophagus and lower oesophageal sphincter in healthy men
pp. 883-888(6)
Authors: Stacher, G.; Schneider, C.; Steinringer, H.; Satzinger, U.; Weber, U.

Prescribing patterns for dyspepsia in primary care: a prospective study of selected general practitioners
pp. 889-2813(1925)
Authors: Bodger, K.; Daly, M.J.; Heatley, R.V.

Time to maximum effect of lansoprazole on gastric pH in normal male volunteers
pp. 897-904(8)
Authors: Bell, N.J.V.; Hunt, R.H.

Effects of ranitidine bismuth citrate on gastric acid secretion and gastrin release in subjects with and without Helicobacter pylori infection
pp. 905-912(8)
Authors: Ciociola, A.A.; Webb, D.D.; Heath, A.; Walsh, J.H.

Effervescent and standard formulations of ranitidine-a comparison of their pharmacokinetics and pharmacology
pp. 913-918(6)
Authors: Watson, R.G.P.; Johnston, B.T.; Tham, T.C.K.; Kersey, K.

Effect of the kappa agonist fedotozine on perception of gastric distension in healthy humans
pp. 919-925(7)
Authors: Coffin, B.; Bouhassira, D.; Chollet, R.; Fraitag, B.; de Meynard, C.; Geneve, J.; Lemann, M.; Willer, J.C.; Jian, R.

Effects of rebamipide on bile acid-induced inhibition of gastric epithelial repair in a rabbit cell culture model
pp. 927-932(6)
Authors: Watanabe, S.; Wang, X.E.; Hirose, M.; Yoshizawa, T.; Iwazaki, R.; Oide, H.; Kitamura, T.; Miwa, H.; Miyazaki,; Sato, N.

Implication of nitric oxide synthase activity in the genesis of water immersion stress-induced gastric lesions in rats: the protective effects of FK506
pp. 933-940(8)
Authors: Hisanaga, Y.; Goto, H.; Tachi, K.; Hayakawa, T.; Sugiyama, S.

5-amino salicylic acid absorption and metabolism in ulcerative colitis patients receiving maintenance sulphasalazine, olsalazine or mesalazine
pp. 941-947(7)
Authors: Stretch, G.L.; Campbell, B.J.; Dwarakanath, A.D.; Yaqoob, M.; Stevenson, A.; Morris, A.I.; Rhodes, J.M.

Adverse events in patients treated with 5-aminosalicyclic acid: 1993-1994 pharmacovigilance report for Pentasa in France
pp. 949-956(8)
Authors: Marteau, P.; Nelet, F.; Le Lu, M.; devaux, C.

Sucralfate and hydrocortisone enemas in the treatment of active ulcerative proctitis-a randomized single-blind comparative study
pp. 957-2813(1857)
Authors: Ardizzone, S.; Petrillo, M.; Antonacci, C.M.; Bianchi Porro, G.

A prospective randomized trial of colchicine in prevention of liver cirrhosis in chronic hepatitis B patients
pp. 961-966(6)
Authors: Lin, D.Y.; Sheen, I.S.; Chu, C.M.; Liaw, Y.F.

Could oral erythromycin optimize high energy continuous enteral nutrition?
pp. 967-973(7)
Authors: Landry, C.; Vidon, N.; Sogni, P.; Nepveux, P.; Chaumeil, J.C.; Couturier, D.; Chaussade, S.

A double-blind randomized trial of low-dose versus high-dose topical anaesthesia in unsedated upper gastrointestinal endoscopy
pp. 975-979(5)
Authors: Mulcahy, H.E.; Greaves, R.R.S.H.; Ballinger, A.; Patchett, S.E.; Riches, A.; Fairclough, P.D.; Farthing, M.J.G.

Intravenous midazolam as a sedative for colonoscopy: a randomized, double-blind clinical trial
pp. 981-984(4)
Authors: Yuno, K.; II.hi, H.; Tatsuta, M.; Hifumi, K.; Omori, M.

Feasibility of analysing [13C]urea breath tests for Helicobacter pylori by gas chromatography-mass spectrometry in the selected ion monitoring mode
pp. 985-995(11)
Authors: Kasho, V.N.; Cheng, S.; Jensen, D.M.; Ajie, H.; Lee, W.N.P.; Faller, L.D.

Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxycillin and either clarithromycin or azithromycin
pp. 997-1000(4)
Authors: Cammarota, G.; Tursi, A.; Papa, A.; Montalto, M.; Veneto, G.; Cuoco, L.; Fedeli, G.; Gasbarrini, G.

High-dose proton pump inhibitor plus amoxycillin for the treatment or retreatment of Helicobacter pylori infection
pp. 1001-1004(4)
Authors: Malaty, H.; El-Zimaity, H.M.T.; Genta, R.M.; Cole, R.A.; Graham, D.Y.

Lansoprazole, clarithromycin and metronidazole for seven days in Helicobacter pylori infection
pp. 1005-2813(1809)
Authors: Harris, A.W.; Pryce, D.I.; Gabe, S.M.; Karim, Q.N.; Walker, M.M.; Langworthy, H.; Baron, J.H.; Misiewicz, J.J.

Helicobacter pylori eradication in clinical practice: one-week low-dose triple therapy is preferable to classical bismuth based triple therapy
pp. 1009-1013(5)
Authors: Goddard, A.F.; Spiller, R.C.

One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients
pp. 1015-1019(5)
Authors: Moshkowitz, M.; Konikoff, F.M.; Peled, Y.; Brill, S.; Hallak, A.; Tiomny, E.; Santo, M.; Bujanover, Y.; Gilat, T.

Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers
pp. 1021-2813(1793)
Authors: Pilotto, A.; Di Mario, F.; Franceschi, M.; Leandro, G.; Soffiati, G.; Scagnelli, M.; Bozzola, L.; Valerio, G.

Randomized comparison of differing periods of twice-a-day triple therapy for the eradication of Helicobacter pylori
pp. 1029-1033(5)
Authors: Laine, L.; Estrada, R.; Trujillo, M.; Fukanaga, K.; Neil, G.

Letters to the Editors
pp. 1035-1036(2)